ANZCA CTN

@anzcactn.bsky.social

ANZCA Clinical Trials Network is a world leader in delivering high quality trial evidence that translates into safe and effective practice in anaesthesia

ANZCA President Professor Dave Story has been interviewed by the ABC about patients not declaring their use of GLP-1 receptor agonists ahead of surgery. 🎧 Listen to the interview here: bit.ly/4pP6vFw 📰 Read the full article here: bit.ly/4p2SG5b

Ozempic-like drugs posing a risk during surgery - ABC listen

Doctors are being forced to delay surgery in some cases because of an increasing number of patients arriving on Ozempic-like drugs, which can pose a heightened risk of life-threatening consequences un...

bit.ly

Congratulations to Dr Sophie Wallace on the successful completion of her PhD at Monash University, titled, 'Consumer engagement in perioperative medical research in Australia.'👩‍🎓📃👏

Bild

The program for the 2026 ANZCA ASM is here! We’re excited to share an incredible line-up of keynote speakers, scientific sessions, workshops, social functions and optional activities, all taking place in Auckland. Explore the program before registration opens on 1 December: bit.ly/4rl1Dcx

Bild

Registration is now open for the FPM Symposium! Join us on Fri 1 May 2026 in Auckland. We'll focus on the science that underpins the practice of pain medicine and the importance of high-quality, evidence-based pain management solutions in achieving brighter futures for our patients. bit.ly/49PJDRm

Bild

ICYMI: Imported IV fluids can contain as much as 60 millilitres of air compared to 5 millilitres in Australian-made products. ANZCA President Dave Story says while the risk of an air embolism is small clinicians need to be aware #anaesthesia @amamedia.bsky.social:

Air inside imported IV fluid bags is posing an extra risk in emergencies

Imported IV fluids containing as much as 12 times more air than those made in Australia are posing a heightened air embolism risk in emergencies for clinicians to manage.

abc.net.au

Congratulations to Professor Kate Leslie AO on receiving the 2025 ASA Award for Excellence in Research! A founding leader and former Chair of the ANZCA Clinical Trials Network, Kate has led major advances in perioperative care and continues to champion diversity and inspire future research leaders.🥳

ANZCA@anzca.bsky.social · last yr.

‪👏👏Drum roll please...congratulations @katy-skier.bsky.social for being awarded the @asahq.bsky.social‬ 2025 Award for Excellence in Research. The award recognises individuals for outstanding #research achievement that has or is likely to have an important impact on the practice of #anesthesiology.

Happy International Clinical Trials Day! Today, we celebrate our dedicated network across Aus & NZ, including our amazing participants & their carers. Your commitment improves safer, better patient care through large-scale trials in anaesthesia, perioperative, and pain medicine. @anzca.bsky.social

ANZCA@anzca.bsky.social · last yr.

Ahead of International Clinical Trials Day on 20 May @anzcactn.bsky.social is acknowledging the important contribution of hundreds of participants in regional hospitals to #clinicaltrials #anaesthesia #research www.anzca.edu.au/anzca-ctn-th...

The Foundation’s named research awards support career development, recognise outstanding investigators, and celebrate donor contributions to research. This year, Professor Story presented 12 awards at this year's ANZCA Foundation reception at #ASM25CNS Read more here bit.ly/431Z2Jg

BildBildBild

Randomising 2,463 high-risk non-cardiac surgery patients to BIS monitoring showed reduced awareness under anaesthesia vs routine care—driving widespread adoption of BIS monitors to prevent awareness. The B-aware study was funded by the ANZCA Foundation. #ASM25CNS

Bild